Third Harmonic Bio Analyst Ratings
Third Harmonic Bio Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/10/2022 | — | Cowen & Co. | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2022 年 10 月 10 日 | — | Cowen & Co. | 启动覆盖范围开启 | → 跑赢大盘 |
Third Harmonic Bio Questions & Answers
第三谐波生物学问答
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Cowen & Co. on October 10, 2022. The analyst firm set a price target for $0.00 expecting THRD to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
Cowen & Co. 于2022年10月10日公布了第三谐波生物（纳斯达克股票代码：THRD）的最新目标股价。该分析公司将目标股价定为0.00美元，预计THRD将在12个月内降至12个月内（可能下跌-100.00％）。1家分析公司去年公布了评级。
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Cowen & Co., and Third Harmonic Bio initiated their outperform rating.
Cowen & Co. 对第三谐波生物（纳斯达克股票代码：THRD）的最新分析师评级由Cowen & Co. 提供，Third Harmonic Bio启动了跑赢大盘的评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on October 10, 2022 so you should expect the next rating to be made available sometime around October 10, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表、与Third Harmonic Bio的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Third Harmonic Bio的最后一次评级是在2022年10月10日提交的，因此您应该预计下一个评级将在2023年10月10日左右公布。
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a initiated with a price target of $0.00 to $0.00. The current price Third Harmonic Bio (THRD) is trading at is $20.01, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的第三谐波生物（THRD）评级最初设定为0.00美元至0.00美元。Third Harmonic Bio（THRD）目前的交易价格为20.01美元，超出了分析师的预期区间。